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Aims Cholera is an acute diarrheal disease that can lead to severe dehydration and death. Antibiotic resistance is a big challenge in infective disease like Cholera. The present study aimed to understand the characteristics and trends of antibiotic resistance of V. cholerae isolations in and around Kashan, Iran.
Instrument & Methods In this descriptive cross-sectional study, samples were gathered using census method from 1998 to 2013 in Kashan, Iran. 1132 fecal samples of patients with acute diarrhea and 237 samples of suspected water samples were taken. The serotypes and biotypes were determined by an enzymatic method. Antibiotic susceptibility test was performed by using Disk Diffusion Method. Data were analyzed using SPSS 23 software. Fisher-exact and Chi-square tests were used to compare the statistical parameters. 
Findings 96 fecal samples (8.5%) and 18 water samples (7.6%) were positive for Vibrio 
cholerae.  Non-agglutinating (Nag) isolates (75.4%) were more common than serotype Inaba 
(13.2%) and Ogawa (11.4%). Nag serotypes were mostly resistant to cefixime (44%) and ampicillin (33%). In contaminated water samples also the most frequent cases were Nag serotype (50%). Nag serotype showed 22.2% of resistance to ampicillin and nitrofurantoin.
Conclusion Vibrio cholerae isolates in Kashan, Iran, are highly resistant to antibiotics, especially Nag serotypes.
A B S T R A C TA R T I C L E    I N F O
Article TypeDescriptive Study
AuthorsAfzali H.1 MD,Momen-Heravi M.* MD,Razzaghi R.1 MD
 Keywords  Vibrio cholerae; Drug Resistance; Serotyping; Multiple Drug Resistance
How to cite this articleAfzali H, Momen-Heravi M,Razzaghi R. Antibiotic Resistanceof Vibrio cholerae Isolates from Kashan, Iran. International Archives of Health Sciences. 2016;3(2):67-71.
Antibiotic Resistance of Vibrio cholerae Isolates from 
Kashan, Iran
©2016 ASP Ins., Afarand Scholarly Publishing Institute, Iran
Copyright© 2016 ASP Ins. This open-access article is published under the terms of the Creative Commons Attribution-NonCommercial 
4.0 International License which permits Share (copy and redistribute the material in any medium or format) and Adapt (remix, transform, 
and build upon the material) under the Attribution-NonCommercial terms.
Antibiotic Resistance of Vibrio cholerae Isolates from Kashan, Iran                   68 
Int Arch Health Sci                             Spring 2016, Vol. 3, Iss. 2 
Introduction 
Cholera is an acute diarrheal disease that can 
lead to severe and rapidly progressive 
dehydration in hours and death. The epidemic 
spread of cholera from the Asia to rest of the 
world attributed to increasing number of trips 
[1]. Drinking water contaminated with human 
feces is the most common way of getting 
cholera. Clinical symptoms include watery 
diarrhea, vomiting, tachycardia, weak pulse, 
orthostatic hypotension, somnolence, and 
eventually coma [2, 3].  
Two serogroups of Vibrio cholerae, O1 and 
O139, cause outbreaks of cholera. O1 causes 
the majority of outbreaks, while O139 first 
was identified in Bangladesh in 1992 and has 
been confined to South-East Asia. V. cholera 
O1 has 2 biotypes, classical and El Tor, and 
each biotype has 2 distinct serotypes, Inaba 
and Ogawa [4, 5]. V. cholerae is best recovered 
from stool specimens using thiosulfate-
citrate-bile salt-sucrose (TCBS) agar where 
the organisms are easily identified by their 
characteristic yellow colonies. Isolates can be 
further characterized through using the 
classic V. cholerae strain agglutinates with 
type O1 antiserum. Organisms that are 
identified biochemically as V. cholerae but do 
not agglutinate with O1-antiserum are 
designated V. cholerae non-O1 serotype or 
NAG (non-agglutinable) V. cholera [6]. NAG 
organisms rarely make the classic V. cholerae 
enterotoxin, but they may make other 
enterotoxins, cytotoxins, and hemolysins. 
Many articles have reviewed the world's 
literature and reported 23 cases of sepsis 
from NAG infection with a 61.5% mortality [7].  
Antibiotic therapy decreases cholera duration 
and fluid loss volume and accelerate the 
clearance of the organism in the feces. Like 
other infective disease, abundant antibiotic 
application has been leaded in drug resistance 
[8]. Different trends of antibiotic resistance of 
V. cholerae have been observed around the 
world [1, 9-11]. In the study performed in Iran by 
Rahbar et al., all strains of V. cholerae were 
resistant to cotrimoxazole, nalidixic-acid and 
furazolidone and were sensitive to 
tetracycline, ciprofloxacin, erythromycin and 
ampicillin [3]. Afzali et al. have shown that the 
sensitivity of cholera to ciprofloxacin, 
doxycycline and tetracycline was 100% and to 
cotrimoxazole and nalidixic-acid was 87.5% 
and 83.5%, respectively [12]. In another study 
performed in Hong Kong, all three strains of V. 
cholerae (1, 2, 3mp) were highly resistant to 
the B-lactamase family and were sensitive to 
tetracycline, chloramphenicol, nalidixic-acid 
and streptomycin [13]. Considering the 
different patterns of sensitivity and resistance 
in V. cholerae, prescription of proper 
antibiotics to treat patients help to prevent 
drug resistance and reduce the costs [14]. 
Continuous monitoring and evaluation of 
antibiotic resistance in various regions can 
help researchers and medical supervisors to 
control and prevent re-epidemic of V. cholera 
[15].  
The present study aimed to understand the 
characteristics and trends of antibiotic 
resistance of V. cholerae isolations in and 
around Kashan, Iran. 
 
Instrument & Methods 
In this descriptive cross-sectional study, 
samples were gathered using census method 
from 1998 to 2013 in Kashan, Iran. 1132 fecal 
samples (rectal swab) of patients with acute 
diarrhea who referred to health centers, 
hospitals and private clinics, and 237 samples 
of suspected water samples were prepared 
and transferred to Cary Blair transport 
medium.  
The samples were transferred to alkaline 
peptone water medium until the pH reached 
to 8.8. Samples were incubated in Thiosulfate 
Citrate Bile Sucrose (TCBS) for 24 hours. The 
serotypes and biotypes were determined by 
an enzymatic method. Antibiotic susceptibility 
test was performed by using Disk Diffusion 
Method (Kirby Bauer). Each isolates was 
tested against eight antibiotics: Ciprofloxacin 
(5µg), Ampicillin (10µg), Cotrimoxazol (25µg), 
Doxycycline (30µg), Tetracycline (30µg), 
Nitrofurantoin (300µg), Cefixime (5µg) and 
Erythromycin (15µg). Standard strains of 
Escherichia coli (ATCC 25922) was used as 
control strains.  
Water suspected to contamination with 
cholera was transferred to holder machine 
and after passing through the filter, cultured 
in TCBS medium and the antibiogram has 
been conducted. To better justification and 
interpretation, the results were classified 
based on some variables like sources, year 
and patients age. Study was approved by the 
ethics committee of the research deputy in 
Kashan University of Medical Sciences.  
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Data were analyzed using SPSS 23 software. 
Fisher-exact (to compare antibiotic resistance 
with water and patient sample) and Chi-
square (to analyze the relationship of 
antibiotic resistance with age and sex) tests 
were used to analyze data.  
 
Findings  
Totally 96 fecal samples (8.5%) and 18 water 
samples (7.6%) were positive for Vibrio 
cholerae. 50 cases (47.3%) of 96 patients were 
male and 46 cases (52.6%) were female 
(p>0.05). 23 cases (21%) were less than 15 
year-old and 73 cases (78.9%) were above 15 
year-old. Antibiotic resistance was more in the 
age group above 15 year-old in all antibiotics 
except ciprofloxacin, doxycycline, and 
tetracycline (Figure 1). 32 samples (33.3%) 
were recorded before 2008. No cases have 
been reported in 2010 and 2011. Resistance 
to all antibiotics has been increased over 15 
years, especially to nitrofurantoin and 
cefixime.  
Non-agglutinating (Nag) isolates (75.4%) 
were more common than serotype Inaba 
(13.2%) and Ogawa (11.4%). Less antibiotic 
resistance was observed in isolated samples 
of contaminated water and they were only 
resistant to 4 antibiotics; ampicillin, 
nitrofurantoin, cotrimoxazole and cefixime. 
However, fecal isolates were resistant to all 
antibiotics; maximum resistance to cefixime 
(37.5%) and the least resistance to 
ciprofloxacin 1.1%. No significant differences 
were observed between two groups of 
patients and contaminated water in antibiotic 
resistance (p>0.05).  
 
Figure 1) Comparison the frequency (Numbers in parentheses are pernectages) of the antibiotic resistance based on 
the sources and age of samples by Fisher Exact test 
Inhibition type 
Source
p Value
Age 
p Value
Patient sample Water sample 15 < 15 ≥ 
Ciprofloxacin 
Susceptible 90 (93.7) 18 (100)
0.999 
69 (71.8) 21 (21.8)
0.5 Intermediate 5 (5.2) 0 4 (4.1) 1 (1) 
Resistant 1 (1.1) 0 0 1 (1) 
Ampicillin 
Susceptible 31 (32.2) 5 (27.7)
0.999 
21 (21.8) 10 (10.4)
0.999 Intermediate 30 (31.2) 8 (44.4) 24 (25) 6 (6.2)
Resistant 35 (36.4) 5 (27.7) 28 (29.1) 7 (7.2)
Cotrimoxazol 
Susceptible 61 (63.5) 13 (72.2)
0.3 
44 (45.8) 17 (17.7)
0.999 Intermediate 16 (16.6) 4 (22.2) 12 (12.5) 4 (4.1)
Resistant 19 (19.7) 1 (5.5) 17 (17.7) 2 (2) 
Doxycycline 
Susceptible 87 (90.6) 17 (94.4)
0.999 
67 (69.7) 20 (20.8)
0.4 Intermediate 6 (6.2) 1 (5.5) 5 (5.2) 1 (1) 
Resistant 3(3.1) 0 1 (1) 2 (2) 
Tetracycline 
Susceptible 81 (84.3) 16 (88.8)
0.999 
63 (65.6) 18 (18.7)
0.5 Intermediate 12 (12.5) 2 (11.1) 9 (9.3) 3 (3.1)
Resistant 3 (3.1) 0 1 (1) 2 (2) 
Nitrofurantoin 
Susceptible 59 (61.4) 13 (72.2)
0.5 
49 (51) 10 (10.4)
0.5 Intermediate 13 (13.5) 2 (11.1) 9 (9.3) 4 (4.1)
Resistant 24 (25) 3 (16.6) 15 (15.6) 9 (9.3)
Cefixime 
Susceptible 52 (54.1) 15 (83.3)
0.2 
44 (45.8) 8 (8.3)
0.01 Intermediate 8 (8.3) 1 (5.5) 2 (2) 6 (6.2)
Resistant 36 (37.5) 2 (11.1) 27 (28.1) 9 (9.3)
Erythromycin 
Susceptible 50 (52) 6 (33.3)
0.999 
35 (36.4) 15 (15.6)
0.07 Intermediate 44 (45.8) 12 (66.6) 37 (38.5) 7 (7.2)
Resistant 2 (2) 0 1 (1) 1 (1) 
 
In fecal samples, 77 isolates (80.2%) were Nag 
serotype, which had the highest level of 
antibiotic resistance. Nag serotypes were 
mostly resistant to cefixime (44%) and 
ampicillin (33%). Ampicillin (32%) got the 
most resistance in Ogawa serotypes, and 
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nitrofurantoin and cotrimoxazol (20%) in 
Inaba serotype. In contaminated water 
samples, also the most frequent cases were 
Nag serotype (50%). Nag serotype showed 
22.2% of resistance to ampicillin and 
nitrofurantoin. It showed intermediate 
resistance to all antibiotics except 
ciprofloxacin and erythromycin. Ampicillin 
and cefixime showed the highest resistance in 
Ogawa serotype (50%). Inaba serotype 
showed no antibiotic resistance in these 
samples. 
 
Discussion 
The aim of this study was to evaluate the 
antibiotic resistance of V. cholerae isolates in 
Kashan, Iran. The results confirm increasing 
problem of bacterial resistance to antibiotics 
in patients by careless consumption or 
administration of antibiotics. As it can be seen 
in literature, various resistance mechanisms 
such as efflux pumps, spontaneous 
chromosomal mutation, conjugative plasmids, 
SXT elements and integrons are involved in V. 
cholerae resistance [16]. 
In a cholera outbreak in Iran in 2005, it was 
reported that antibiotic resistance to 
cotrimoxazol, nalidixic acid and furazolidone 
were 100 %, whereas antibiotic sensitivity to 
tetracycline, ciprofloxacin, erythromycin and 
ampicillin were 100 % [3]. While Afzali et al. 
have shown antibiotic sensitivity of V. 
cholerae to ciprofloxacin, doxycycline, and 
tetracycline (100%), ceftizoxim (95.8%) , 
cotrimoxazol (87.5%) , nalidixic-acid (83.3%) 
, and ampicillin (62.5%) [12]. In another study 
in Malaysia, have reported that all strains 
isolated from coastal waters were sensitive to 
cotrimoxazol, erythromycin and ciprofloxacin 
and most antibiotic resistance was to 
doxycycline [17]. In the present study, the 
highest antibiotic resistance was for Nag 
serotype, whereas the lowest was for Inaba 
serotype which was 100% sensitive to all 
antibiotics. Many studies, like Wang et al. [13], 
Batra et al. [18] and Zhang et al. [19] have 
demonstrated that generally antibiotic 
resistance in Inaba serotype is lower than 
other serotypes. 
Increasing body of evidences demonstrate 
that antibiotic therapy has increased 
antibiotic resistance of V. cholerae 
dramatically [9, 20], which was reached from 1 
antibiotic in 1998 to 3 antibiotics in 2004. 
Similar to current study, some previous 
researches indicate on increasing rate of 
antibiotic resistance during years. Faruque et 
al., for example report at the beginning of 
1998 antibiotic resistance of cotrimoxazole 
(0%), tetracycline (2.5%), and ciprofloxacin 
(4.6%) reached to 10.2%, 13.6% and 12.4% in 
2004, respectively [21]. No significant 
differences were observed in the antibiotic 
resistance among sexes in the present study, 
however,  other studies reported a significant 
higher resistance among men than women [22, 
23].  
The results of this study reveal that resistance 
increases among selective antibiotics for 
treatment of V. cholerae in recent years, which 
can be dangerous for treatment due to the 
emergence of multidrug resistance strains. 
Therefore, frequent monitoring and 
surveillance of cholera outbreak is useful. The 
increase in antibiotic resistance among strains 
isolated from the environment should be 
considered.  
 
Conclusion  
Vibrio cholerae isolates in Kashan, Iran, are 
highly resistant to antibiotics, especially Nag 
serotypes.  
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